GENOOX, founded in 2014, is a pioneering company in the intersection of AI, Cloud Infrastructure, and Health Care. Known for its slogan, "Genoox harnesses the power of its community to enable actionable insights, serving professionals at the point of care," the company is making a significant impact in the genomic data space.
The company's standout platform, Franklin, builds on a cloud-based AI infrastructure to connect clinicians, genetic counselors, and healthcare organizations. It is utilized by over 1,700 health organizations across 44 markets globally, providing users with advanced genomic tools and the ability to make impactful discoveries at the point of care.
Headquartered in the United States, GENOOX most recently secured an $8.00M Series B investment on 01 February 2021, backed by investors like TriVentures, Glilot Capital, Inimiti, IN Venture, and Infinity Medical. This robust support underscores its potential in transforming healthcare delivery.